MET inhibitors in advanced non-small-cell lung cancer: a meta-analysis and review

The alterations of MET have been detected in non-small-cell lung cancer (NSCLC). However, survival benefit of MET inhibitors remains controversial. We performed this meta-analysis to evaluate the survival benefit of MET inhibitors combined with an epidermal growth factor receptor tyrosine kinase inh...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncotarget
Hoofdauteurs: Kim, Jung Han, Kim, Hyeong Su, Kim, Bum Jun
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Impact Journals LLC 2017
Onderwerpen:
Meta-Analysis
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5650440/
https://ncbi.nlm.nih.gov/pubmed/29088885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20824
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items